Tag: Net Sales Driven
-
Almirall Reports Strong 2025 Growth, Surpasses €1 Billion in Net Sales Driven by Dermatology Portfolio
Almirall, the Barcelona-based global biopharmaceutical company, reported strong financial results for 2025, achieving double-digit growth across key performance metrics and reinforcing its leadership in medical dermatology. The company recorded net sales of €1.108 billion, marking a 12.4% increase compared to 2024. Total revenue rose 12.5% to €1.114 billion, while EBITDA grew significantly by 20.9% to…